Catherine Bryson
About Catherine Bryson
Catherine Bryson is the Operations Portfolio Lead IBD at Bristol Myers Squibb with extensive experience in clinical operations and drug development.
Current Position at Bristol Myers Squibb
Catherine Bryson currently serves as the Operations Portfolio Lead IBD at Bristol Myers Squibb. In this role, she is responsible for overseeing operational portfolios within the immunology, cardiovascular, and dermatology sectors, managing key projects, and ensuring their alignment with the company's strategic goals.
Previous Role as Clinical Operations Lead for Lung at Bristol-Myers Squibb
From 2017 to 2020, Catherine Bryson held the position of Clinical Operations Lead for Lung at Bristol-Myers Squibb in Princeton, NJ, USA. During her tenure, she managed clinical operations for lung-related clinical trials, coordinating efforts with cross-functional teams to advance the company's clinical research objectives.
Director Roles at Vitae Pharmaceuticals
Between 2009 and 2017, Catherine Bryson worked at Vitae Pharmaceuticals, holding two significant positions. From 2014 to 2017, she was the Director of R&D Operations at an Allergan affiliate in Fort Washington, PA. In this role, she supervised research and development operations, focusing on innovation and operational efficiency. Prior to this, she was the Director of Clinical Operations from 2009 to 2014, where she directed clinical trials and established clinical organizations for the company.
Experience at Pharmacopeia
In 2007-2008, Catherine Bryson served as Director of Clinical Development at Pharmacopeia. Her responsibilities included managing the clinical development processes, ensuring compliance with regulatory standards, and overseeing the progression of clinical trials.
Long Tenure at Bristol-Myers Squibb
From 1988 to 2007, Catherine Bryson was a Senior Clinical Protocol Manager at Bristol-Myers Squibb. Over her 19-year tenure, she gained extensive experience in clinical protocol management, contributing to numerous clinical trials and clinical research projects, solidifying her expertise in clinical operations.
Educational Background
Catherine Bryson holds dual Bachelor of Arts degrees in English and Biology from Franklin & Marshall College. Her educational background has provided her with a unique blend of skills that supports her comprehensive understanding of both scientific and operational aspects of clinical research.
Drug Development Expertise
Catherine Bryson has deep knowledge of the drug development process from pre-clinical and toxicology studies through the New Drug Application (NDA) phase. This expertise enables her to effectively manage and oversee various stages of drug development, ensuring that projects meet regulatory requirements and company objectives.
Stakeholder Management
Throughout her career, Catherine Bryson has successfully managed diverse groups of stakeholders, including consultants, key opinion leaders, and contract research organizations (CROs). Her ability to coordinate and lead such varied groups has been critical in advancing clinical and operational projects within her roles.